News

Brescia, 19/3/2020 

Leggiamo con stupore e vivo rammarico l’articolo appena pubblicato da Repubblica a firma del vicedirettore, Gianluca di Feo, intitolato: ”Coronavirus, mezzo milione di tamponi da un'azienda di Brescia agli Stati Uniti”. Riteniamo sia doveroso puntualizzare quanto segue, a tutela del buon nome di Copan, dei nostri dipendenti e concittadini.

3rd February 2020

Synthetic fiber swabs with plastic shafts and viral transport medium are elective collection materials for nasopharyngeal and oropharyngeal sampling in 2019-nCoV suspected patients, CDC interim guidelines say.

22 November 2019
Copan Flock Technologies was incorporated in 2004 as a wholly-owned subsidiary of Copan Italia, with a precise goal: improve pre-analytics in the field of infectious diseases diagnostics through the introduction, development, and manufacturing of the revolutionary collection devices known as FLOQSwabs®.

24 January 2019
Unceasingly, Copan is fostering the culture of sponsoring and supporting good causes. Passion for supporting health initiatives worldwide is in our DNA.

04 June 2018

Brescia, Italy – June 1st, 2018 COPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics Inc. announced today that they have filed a lawsuit against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC, in the United States District Court for the District of Maine for infringement of U.S. Patent No. 8,114,027, U.S. Patent No. 8,317,728, U.S. Patent No. 8,979,784, U.S. Patent No. 9,011,358, and U.S. Patent No. 9,173,779. 

Page 1 of 2